Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Trading Statement

7 Nov 2022 07:00

RNS Number : 4456F
Kingspan Group PLC
07 November 2022
 

Kingspan Group Plc

Trading Update

 

07 November 2022

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, today issues a Trading Update for the period to 30 September 2022.

Sales in the nine month period to 30 September were €6.25bn, up 33% on the same period in the prior year, with sales growth of 17% in the third quarter. Underlying sales (pre currency and acquisitions) were up 20% in the year to date and by 9% in the third quarter.

 

Insulated Panels sales increased by 29% in the first nine months and by 13% in the third quarter. Underlying sales were up 23% year to date and up 7% in the third quarter. Global sales volumes in the third quarter were expectedly sluggish reflecting the slowdown in order placement flagged mid-year. Undoubtedly, a factor has been expectations around raw material pricing with some pick up in order placement post the summer period. We have been carrying higher levels of inventory than normal for much of the year and, as certain inputs have seen deflation more recently, this has had a short-term impact on margins as these materials sell through. In general, activity in the Americas has held up reasonably well, as has Germany and the UK with softer activity elsewhere in Europe. We continue to advance our innovation agenda notably QuadCore™ LEC Panel comprising an estimated 45% of recycled materials and with 40% less embodied carbon.

 

Insulation sales in the first nine months were up 48% and up 20% in the third quarter. Underlying sales were up 12% year to date and by 8% in the third quarter. The sales growth experienced in the third quarter was price led reflecting input inflation with rigid board volumes soft overall with decreased residential activity a factor. Technical insulation, in particular district heating applications, continued to experience the momentum seen in the first half. The Troldtekt business acquired earlier in the year is integrating well and significant progress has also been made in the natural insulation category with bio-based materials for ultra-low embodied carbon insulation. Encouragingly, AlphaCore® is building a specification bank and is likely to advance further in the years ahead.

 

Light + Air sales in the first nine months were up 33% and by 26% in the third quarter. Underlying sales were up 17% year to date and by 18% in the third quarter. Most end markets performed well reflecting the positive orderbook year on year and the division is on track to record margin progression for the year.

 

Roofing + Waterproofing had a milestone third quarter with the completion of the acquisition of Ondura Group in September. The division now has annualised revenues of approximately €500m including the acquisition of Derbigum in June 2022. Furthermore, in August 2022 the Group acquired a 24% strategic minority stake in Nordic Waterproofing. A significant element of the new division is European and our ambition, and the opportunity, is global.

 

Data + Flooring sales in the first nine months were up 32% and up 33% in the third quarter. Underlying sales were up by 24% in the first nine months and were up 25% in the third quarter. Datacentre activity continues to drive performance and the pipeline of activity is encouraging as we head towards 2023.

 

Water + Energy sales in the first nine months increased by 12% and up 5% in the third quarter. Underlying sales were up 6% year to date and were up 1% in the third quarter.

 

Net debt at the end of December 2022 is expected to be in the region of €1.5bn (net debt/EBITDA 1.5x) reflecting a 2022 development spend in excess of €1.2bn (acquisitions approximately €1.0bn and organic investment approximately €0.2bn). Year end liquidity, representing cash balances and undrawn committed facilities, is expected to exceed €1.5bn with the Group's average cost of debt standing at 1.85%.

 

Looking ahead

A feature of the current environment is the lack of visibility beyond the next short period of months. Sentiment is cautious for the most part although not uniformly so. The sharp increases we have seen in raw material prices over the last eighteen months appear to have peaked, at least for now. Certain key inputs are likely to reduce in price in the fourth quarter. The global backlog of orders has been reasonably stable over the past three months. The activity pipeline in data, technology, EV automotive and district heating applications are all notable positives.

 

There is still some way to go in 2022 with the seasonally important fourth quarter remaining and, accordingly, we expect to deliver a full year trading profit in the region of €830m, significantly ahead of the €755m recorded in 2021.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

Pat Walsh, Murray Consultants Tel: +353 (0) 1 4980300

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVZLFBLFLLFBQ
Date   Source Headline
12th Feb 20145:32 pmRNSBlocklisting Application
5th Feb 201412:48 pmRNSHolding(s) in Company
2nd Jan 20143:19 pmRNSHolding(s) in Company
2nd Jan 20147:00 amRNSBlocklisting Interim Review
2nd Jan 20147:00 amRNSTotal Voting Rights
16th Dec 201310:09 amRNSHolding(s) in Company
6th Dec 20135:43 pmRNSHolding(s) in Company
27th Nov 20135:21 pmRNSHolding(s) in Company
26th Nov 201310:51 amRNSHolding(s) in Company
22nd Nov 20137:00 amRNSInvestor & Analyst Seminar
19th Nov 201312:56 pmRNSHolding(s) in Company
14th Nov 20133:59 pmRNSHolding(s) in Company
13th Nov 20133:14 pmRNSDirector/PDMR Shareholding
11th Nov 20137:00 amRNSInterim Management Statement
7th Nov 201312:01 pmRNSHolding(s) in Company
1st Nov 201311:24 amRNSTotal Voting Rights
29th Oct 20134:53 pmRNSHolding(s) in Company
21st Oct 201310:52 amRNSDirector/PDMR Shareholding
15th Oct 20135:21 pmRNSHolding(s) in Company
1st Oct 20139:36 amRNSTotal Voting Rights
25th Sep 20131:00 pmRNSHolding(s) in Company
24th Sep 20131:06 pmRNSHolding(s) in Company
17th Sep 201310:02 amRNSDirector/PDMR Shareholding
2nd Sep 20139:47 amRNSTotal Voting Rights
19th Aug 20137:00 amRNSHalf Yearly Report
2nd Jul 20134:28 pmRNSHolding(s) in Company
1st Jul 201311:26 amRNSBlocklisting Interim Review
1st Jul 201311:23 amRNSTotal Voting Rights
14th Jun 201312:10 pmRNSHolding(s) in Company
12th Jun 20134:09 pmRNSHolding(s) in Company
4th Jun 20135:29 pmRNSDirector Declaration
4th Jun 201310:28 amRNSTotal Voting Rights
21st May 20134:44 pmRNSHolding(s) in Company
13th May 20135:40 pmRNSHolding(s) in Company
9th May 201310:56 amRNSResult of AGM
9th May 20137:00 amRNSInterim Management Statement
1st May 201312:30 pmRNSTotal Voting Rights
11th Apr 20134:07 pmRNSHolding(s) in Company
5th Apr 20137:00 amRNSAnnual Financial Report
2nd Apr 201311:26 amRNSTotal Voting Rights
27th Mar 20134:34 pmRNSDirector/PDMR Shareholding
26th Mar 20134:20 pmRNSDirector/PDMR Shareholding
7th Mar 20136:25 pmRNSHolding(s) in Company
4th Mar 20133:19 pmRNSDirector/PDMR Shareholding
1st Mar 20137:00 amRNSTotal Voting Rights
26th Feb 201311:57 amRNSDirector/PDMR Shareholding
25th Feb 20137:00 amRNSFinal Results
25th Feb 20137:00 amRNSMain Securities Market Notice
11th Feb 20135:03 pmRNSBlock Listing Application
6th Feb 20137:00 amRNSDirector Declaration - Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.